Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
Speaker 2: Stock Movers Report, your roundup of companies making moves in
Speaker 2: the stock market, harnessing the power of Bloomberg Data.
Speaker 3: Let's take a look at some stocks on the move today.
Speaker 3: I'm Alexandra Semenova with Scarlett fou and we are joined
Speaker 3: by Bloomberg's Carmen Ryannikey, Deputy team leader for US Equities. Carmen,
Speaker 3: what is on your radar today?
Speaker 4: Yeah, so the big one, the first one I'm going
Speaker 4: to cover is Dell ticker d EL. Shares are up
Speaker 4: thirty three percent right now intra day. This is on
Speaker 4: track to close it a record high. It's at an
Speaker 4: intra day high. So, the hardware hardware maker excuse Me,
Speaker 4: had earnings and it gave an outlook for annual sales
Speaker 4: that beat analyst estimates. And we're specifically fueled by demand
Speaker 4: for its servers that power AI work. So they said
Speaker 4: that their revenue for the fiscal year twenty twenty seven
Speaker 4: will be about one hundreds sixty seven billion, which includes
Speaker 4: sixty billion from the sale of AI servers, which is
Speaker 4: much higher than analyst estimates of about one hundred and
Speaker 4: forty two billions. So this was a really solid earning support.
Speaker 4: Analysts have been cheering it and saying, you know this,
Speaker 4: this company has been an AI winner and it continues
Speaker 4: to be.
Speaker 1: I love the comment from a analyst which basically said
Speaker 1: that Dell is an example of the dinosaur tech firm
Speaker 1: rediscovering a new lease on life as an AI powerhouse,
Speaker 1: earning the ranks of Intel or Cisco or Nokio or Lenovo.
Speaker 1: So Dell, it's like a throwback to the nineties. It
Speaker 1: is all right, what's your next stock?
Speaker 3: Yep?
Speaker 4: So this is Reprimune ticker rip ols. This is a
Speaker 4: tiny little biotech stock, but I think it's worth a mention.
Speaker 4: So the shares are up seventy six percent right now.
Speaker 4: This is the best intro day jump since twenty twenty five.
Speaker 4: So the company said that US regulators would reconsider a
Speaker 4: skin cancer treatment, and this is important because it's been
Speaker 4: rejected from regulators to prior times. So a path forward
Speaker 4: with the FDA is really positive for this company.
Speaker 3: And what else are you watching?
Speaker 1: Krtman?
Speaker 4: Yes, so one on the flip side, let's look at
Speaker 4: shares of ASTs space Mobile so or sorry, AST space
Speaker 4: Mobile ticker is ASTs. The stock is down twenty percent
Speaker 4: right now about twenty percent. This is the worst intra
Speaker 4: day performance since twenty twenty four. This is off of
Speaker 4: Blue Origins a New Glen rocket explosion. So ASTs previously
Speaker 4: used Blue Origins New Gun to launch one of their satellites,
Speaker 4: and there was actually an issue with that launch as well,
Speaker 4: so the rocket failed to put the satellite in orbit.
Speaker 4: Analysts are saying that the problem now with New gleun
Speaker 4: will delay full deployment of AST satellite network and sort
Speaker 4: of push back some of the timelines for a commercial
Speaker 4: launch for AST. So I'm going to see further delays
Speaker 4: there as they figure out what happened to that.
Speaker 2: The Stockmovers report from Bloomberg Radio. Check back with us
Speaker 2: throughout the day for the latest roundup of companies making
Speaker 2: news on Wall Street and for the latest market moving headlines.
Speaker 2: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
Speaker 2: dot com, and on Applecarplay and Android Auto with the
Speaker 2: Bloomberg Business app.